Cingulate Inc. Additional Paid in Capital
Cingulate Inc. (CING) had Additional Paid in Capital of $171.02 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-08-13
- 2026-06-30: Additional Paid in Capital $171.02M.
- 2026-03-31: Additional Paid in Capital $160.55M.
- 2025-12-31: Additional Paid in Capital $134.88M.
- 2025-09-30: Additional Paid in Capital $129.58M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2026-06-30 | $171.02M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $160.55M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $134.88M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $129.58M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $122.59M 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $118.22M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $117.38M 10-K · filed 2026-03-18 | $115.94M 10-K · filed 2025-03-27 |
| 2024-09-30 | $114.39M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $102.21M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $99.13M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $86.07M 10-K · filed 2025-03-27 | $86.07M 10-K · filed 2024-04-01 |
| 2023-09-30 | $85.91M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $73.93M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $73.49M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $73.29M 10-K · filed 2024-04-01 | $73.29M 10-K · filed 2023-03-10 |
| 2022-09-30 | $73.17M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $72.96M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $72.76M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $72.57M 10-K · filed 2023-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |